Arkolith/Insider Trading/OVID/Form 4

Levin Jeremy M

CEO, Director, 10% OwnerOvid Therapeutics Inc. (OVID) · full profile →Form 4 · filed Feb 26, 2019
Net Buying
Open-Market Buys
$150K
Open-Market Sells
$0
Net Open-Market Flow
$150K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 22, 2019Buy(P)75K$2.00$150K4.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2019Grant(A)250K—$0250K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-19-013905) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Ovid Therapeutics Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp